SCHEMBL18155195

SCHEMBL18155195

COc1cc(C)ccc1N1Cc2ccccc2C1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.65
MAPT P10636 7/20 0.65
HPGD P15428 2/20 0.65
LMNA P02545 3/20 0.58
SMN1; SMN2 Q16637 2/20 0.53
RAB9A P51151 2/20 0.53
ALOX15 P16050 1/20 0.53
HSD17B10 Q99714 1/20 0.53
ACHE P22303 1/20 0.46
NPC1 O15118 1/20 0.46
POLB P06746 1/20 0.46
KDM4E B2RXH2 1/20 0.45
HTT P42858 1/20 0.44
DRD2 P14416 1/20 0.44
DRD3 P35462 1/20 0.44
HTR1A P08908 2/20 0.43
HTR3A P46098 2/20 0.43
GAA P10253 1/20 0.41
GRIN2D O15399 1/20 0.40
GRIN3B O60391 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30358126 0.78 ALDH1A1 (0.67) ALDH1A1MAPTHPGDLMNASMN1; SMN2
SCHEMBL18155343 0.78 ALDH1A1 (0.67) ALDH1A1MAPTHPGDLMNASMN1; SMN2
SCHEMBL12082468 0.78 DRD2 (0.62) ALDH1A1MAPTLMNASMN1; SMN2ACHE
SCHEMBL13023352 0.78 TUBB4A (0.45) ALDH1A1MAPTHPGDLMNAHSD17B10
SCHEMBL13023405 0.78 MEN1 (0.45) ALDH1A1MAPTHPGDLMNAHSD17B10
SCHEMBL8342531 0.77 ALDH1A1 (0.61) ALDH1A1MAPTLMNASMN1; SMN2ACHE
SCHEMBL17191282 0.76 ALDH1A1 (0.52) ALDH1A1MAPTHPGDLMNASMN1; SMN2
SCHEMBL21015682 0.76 ALDH1A1 (0.52) ALDH1A1MAPTHPGDLMNASMN1; SMN2
SCHEMBL12385910 0.76 ALDH1A1 (0.59) ALDH1A1MAPTLMNASMN1; SMN2ACHE
SCHEMBL15759137 0.76 ALDH1A1 (0.52) ALDH1A1MAPTHPGDLMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9468632-B2 Methods and compositions for targeting cancer stem cells THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2016-10-18 US disclosed